Bevacizumab or laser for aggressive posterior retinopathy of prematurity

PURPOSE: The purpose of this study was to report the rate of reactivation and structural outcome, after the laser or bevacizumab treatment for aggressive posterior retinopathy of prematurity (APROP). METHODS: Retrospective chart review was conducted on consecutive infants with APROP treated with (1)...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Taiwan J Ophthalmol
Päätekijät: Blair, Michael, Gonzalez, Jose Maria Garcia, Snyder, Laura, Schechet, Sidney, Greenwald, Mark, Shapiro, Michael, Rodriguez, Sarah Hilkert
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Medknow Publications & Media Pvt Ltd 2018
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6302568/
https://ncbi.nlm.nih.gov/pubmed/30637196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_69_18
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia